Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2004, p. 1361-1364, Vol. 48, No. 4
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.4.1361-1364.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Departments of Laboratory Medicine,1 Internal Medicine,2 Committee of Infection Control, National Taiwan University Hospital,3 School of Medical Technology, National Taiwan University College of Medicine, Taipei, Taiwan4
Received 3 June 2003/ Returned for modification 1 September 2003/ Accepted 30 December 2003
A rapid emergence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection (from 26.3% in 1986 to 77% in 2001) was found. The susceptibility of 200 nonduplicate blood isolates of MRSA and 100 MRSA isolates causing refractory bacteremia to 22 antimicrobial agents disclosed that glycopeptides, quinupristin-dalfopristin, and linezolid remained the most active agents.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»